In this video, Alex Carlson, the Editor-in-Chief of InsiderFinancial.com, recounts what’s happening so far this week on the OTC Markets and his...
The controversy surrounding CytoDyn Inc. (OTCMKTS: CYDY) stock is startling. An aggressive pack of short sellers claim its leronlimab Covid trial didn’t...
The hottest market sector right now concerns NFTs. Non-fungible tokens, essentially unique digital collectibles, have boomed this year as endorsements from the...
Alex Carlson, the Editor-in-Chief of InsiderFinancial.com, discusses his market outlook for the week of March 22 to 26. BOTTOM LINE As we...
It was a choppy start on the OTC Markets for the week of March 15 to 19. We gave everyone our penny...
The past few weeks have been hard on many traders. Most are looking at a sea of red in their portfolios. This...
6 endpoints met after full data release so shorts double down on trial failure narrative Investors in CytoDyn Inc. (OTCMKTS: CYDY) are...
Alex Carlson, the Editor-in-Chief of InsiderFinancial.com, covers the last week and the penny stock outlook for the coming week. BOTTOM LINE As...
